Rapid disintegrating tablets of simvastatin dispersions in polyoxyethylene–polypropylene block copolymer for maximized disintegration and dissolution

References

• HiraniJJRathodDAVadaliaKROrally disintegrating tablets: a reviewTropical Journal of Pharmaceutical Research200982161172
   Web of Science ®Google Scholar
• PabariRMRamtoolaZApplication of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tabletsInt J Pharm20124301–2182522465631
   PubMed Web of Science ®Google Scholar
• FuYYangSJeongSHKimuraSParkKOrally fast disintegrating tablets: developments, technologies, taste-masking and clinical studiesCrit Rev Ther Drug Carrier Syst200421643347615658933
   PubMed Web of Science ®Google Scholar
• ShuklaDChakrabortySSinghSMishraBFabrication and evaluation of taste masked resinate of risperidone and its orally disintegrating tabletsChem Pharm Bull (Tokyo)200957433734519336927
   PubMed Web of Science ®Google Scholar
• KawanoYItoASasatsuMMachidaYOnishiHPreparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation methodYakugaku Zasshi20101301217371742 Japanese21139401
   PubMed Web of Science ®Google Scholar
• HuXLiYZhangEPreparation and evaluation of orally disintegrating tablets containing taste-masked microcapsules of berberine hydrochlorideAAPS PharmSciTech2013141293723180226
   PubMed Web of Science ®Google Scholar
• SmithDGEpidemiology of dyslipidemia and economic burden on the healthcare systemAm J Manag Care200713Suppl 3S68S7117596114
   PubMed Web of Science ®Google Scholar
• WietlisbachVMarques-VidalPKuulasmaaKKarvanenJPaccaudFProjectWMThe relation of body mass index and abdominal adiposity with dyslipidemia in 27 general populations of the WHO MONICA ProjectNutr Metab Cardiovasc Dis201323543244222209742
   PubMed Web of Science ®Google Scholar
• HakanenMLagstromHKaitosaariTDevelopment of overweight in an atherosclerosis prevention trial starting in early childhood. The STRIP studyInt J Obes (Lond)200630461862616446743
   PubMed Web of Science ®Google Scholar
• SuTCLiaoCCChienKLHsuSHSungFCAn overweight or obese status in childhood predicts subclinical atherosclerosis and prehypertension/hypertension in young adultsJ Atheroscler Thromb201421111170118225030049
   PubMed Web of Science ®Google Scholar
• DanielsSRGreerFRCommittee on NutritionLipid screening and cardiovascular health in childhoodPediatrics2008122119820818596007
   PubMed Web of Science ®Google Scholar
• BelayBBelamarichPFTom-RevzonCThe use of statins in pediatrics: knowledge base, limitations, and future directionsPediatrics2007119237038017272627
   PubMed Web of Science ®Google Scholar
• WilliamsDFeelyJPharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitorsClin Pharmacokinet200241534337012036392
   PubMed Web of Science ®Google Scholar
• EilandLSLuttrellPKUse of statins for dyslipidemia in the pediatric populationJ Pediatr Pharmacol Ther201015316017222477808
   PubMedGoogle Scholar
• KangBKLeeJSChonSKDevelopment of self-microemulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogsInt J Pharm20042741–2657315072783
   PubMed Web of Science ®Google Scholar
• JiangTHanNZhaoBXieYWangSEnhanced dissolution rate and oral bioavailability of simvastatin nanocrystal prepared by sonoprecipitationDrug Dev Ind Pharm201238101230123922229827
   PubMed Web of Science ®Google Scholar
• VarshosazJTavakoliNSalamatFAEnhanced dissolution rate of simvastatin using spherical crystallization techniquePharm Dev Technol201116552953520684739
   PubMed Web of Science ®Google Scholar
• RoweRCSheskeyPJQuinnMEAmerican Pharmacists AssociationHandbook of Pharmaceutical ExcipientsLondon; Chicago; Washington DCPharmaceutical Press; American Pharmacists Association2009
   Google Scholar
• NewaMBhandariKHLiDXPreparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188Int J Pharm20073431–222823717597315
   PubMed Web of Science ®Google Scholar
• GuzikLMrozikWKamyszWDetermination of simvastatin in pharmaceutical dosage forms by optimized and validated method using HPLC/UVCroat Chem Acta2010834371377
   Web of Science ®Google Scholar
• AndersonNHBauerMBoussacNKhan-MalekRMundenPSardaroMAn evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profilesJ Pharm Biomed Anal1998174–58118229682166
   PubMed Web of Science ®Google Scholar
• LateSGYuYYBangaAKEffects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tabletsInt J Pharm20093651–241118778759
   PubMedGoogle Scholar
• SandeepKSureshPDGGEffect of non ionic surfactant on the solubility and dissolution of simvastatinInt Res J Pharm201123100102
   Google Scholar
• CirriMMuraPRabascoAMGinesJMMoyanoJRGonzalez- RodriguezMLCharacterization of ibuproxam binary and ternary dispersions with hydrophilic carriersDrug Dev Ind Pharm2004301657415000431
   PubMed Web of Science ®Google Scholar
• AffandiMMRMMTripathyMShahYAAMajeedABASolubility enhancement of simvastatin by arginine: thermodynamics, solute-solvent interactions, and spectral analysisDrug Des Dev Ther201610959969
   PubMed Web of Science ®Google Scholar
• BettinettiGPSorrentiMRossiSFerrariFMuraPFaucciMTAssessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSCJ Pharm Biomed Anal20023041173117912408907
   PubMed Web of Science ®Google Scholar
• SharmaAJainCPTanwarYSPreparation and characterization of solid dispersions of carvedilol with poloxamer 188J Chil Chem Soc201358115531557
   Web of Science ®Google Scholar
• RaoMMandageYThankiKBhiseSDissolution improvement of simvastatin by surface solid dispersion technologyDissolut Technol20101722734
   Web of Science ®Google Scholar
• BattuSKRepkaMAMajumdarSMadhusudanRYFormulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrantsDrug Dev Ind Pharm200733111225123218058319
   PubMed Web of Science ®Google Scholar
• SammourOAHammadMAZidanASMowafyAGQbD approach of rapid disintegrating tablets incorporating indomethacin solid dispersionPharm Dev Technol201116321922720163325
   PubMed Web of Science ®Google Scholar
• FenyvestEAntalBZsadonBSzejtliJCyclodextrin polymer, a new tablet disintegrating agentDie Pharmazie19843974734756494226
   PubMed Web of Science ®Google Scholar
• ZhangGYangJLiuHZhangJSludge ozonation: disintegration, supernatant changes and mechanismsBioresour Technol200910031505150918835154
   PubMed Web of Science ®Google Scholar
• PabariRRamtoolaZEffect of a disintegration mechanism on wetting, water absorption, and disintegration time of orodispersible tabletsJ Young Pharm20124315716323112534
   PubMedGoogle Scholar
• HasegawaANakagawaHSugimotoIThe mechanism of disintegration time increase of tablets containing hydroxypropylcellulose by moisture absorptionYakugaku Zasshi19841045544547 Japanese6491896
   PubMed Web of Science ®Google Scholar
• MathialaganTViraraghavanTBiosorption of pentachlorophenol by fungal biomass from aqueous solutions: a factorial design analysisEnviron Technol200526557157915974275
   PubMed Web of Science ®Google Scholar
• CarlyleWMMontgomeryDCRungerGCOptimization problems and methods in quality control and improvementJ Qual Technol2000321117
   Web of Science ®Google Scholar
• van WijkJPBuirmaRvan TolAEffects of increasing doses of simvastatin on fasting lipoprotein subfractions, and the effect of high-dose simvastatin on postprandial chylomicron remnant clearance in normotriglyceridemic patients with premature coronary sclerosisAtherosclerosis2005178114715515585212
   PubMed Web of Science ®Google Scholar